The other two studies involved a total of 1,159 patients with later stage disease, where AZILECT was added to the patients’ existing treatment including levodopa. ###>Les deux autres études ont porté sur 1 159 patients atteints d’ un stade avancé de la maladie, AZILECT étant ajouté au traitement existant des patients comprenant lévodopa.